Staar Surgical shareholders appear to reject Alcon's increased $1.6B buyout offer after Broadwood Partners leads opposition ...
Credo Technology Group (CRDO) is a $27 billion provider of high-performance, high-bandwidth serial connectivity solutions for ...
I reiterate Credo Technology as a Strong Buy after delivering record Q2 2026 results and raising full-year guidance. CRDO achieved 272% y/y revenue growth to $268M and a 47.7% non-GAAP net margin, ...
The Chosun Ilbo on MSN
Marathon gold medalist advises smiling to revitalize running rhythm
On days when your condition is not good, try to make a bright expression on purpose.” Ji Young-jun, a gold medalist in the ...
The state of the acute-care system in the Edmonton zone is an absolute crisis. I have never seen it this bad,' said a Royal ...
Staar Surgical announced that preliminary estimates suggest that it failed to receive stockholder approval for its planned ...
Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger ...
CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST.
GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (ALC) CEO David Endicott will present at the 2026 J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, at 8:15 a.m. PST. A live webcast of ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback